Plexus (PLXS) Up 1.4% Since Last Earnings Report: Can It Continue?
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock?
PLXS - Plexus Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$305.00
DETAILS
HIGH:
$330.00
LOW:
$275.00
MEDIAN:
$310.00
CONSENSUS:
$305.00
UPSIDE:
23.32%
Stock News
Can Plexus (PLXS) Climb 25.22% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Plexus (PLXS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Deutsche Bank AG Buys Shares of 30,495 Plexus Corp. $PLXS
Deutsche Bank AG purchased a new position in shares of Plexus Corp. (NASDAQ: PLXS) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 30,495 shares of the technology company's stock, valued at approximately $9,169,000. Deutsche Bank AG owned about 0.11% of Plexus
Buy 3 Momentum Anomaly Stocks as Surging Oil Prices Rattle Markets
Oil-price volatility is shaking markets, but Plexus, Twilio and MACOM stand out as momentum stocks with strong one-year gains and recent pullbacks.
Earnings Estimates Rising for Plexus (PLXS): Will It Gain?
Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Plexus (PLXS) Is Up 7.56% in One Week: What You Should Know
Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
These 4 Electronics-Manufacturing Stocks Are Surging, and It's Still Time to Buy
Electronics manufacturing services (EMS) providers are benefiting from a powerful combination of secular technology investment, rising product complexity, and increased outsourcing by original equipment manufacturers (OEMs).
Plexus Corp. $PLXS Shares Purchased by Amundi
Amundi boosted its holdings in shares of Plexus Corp. (NASDAQ: PLXS) by 143.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,294 shares of the technology company's stock after acquiring an additional 18,418 shares during the period.
Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?
Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.
Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns
PLXS' broad Q3 beat and stronger growth outlook extend its runway, but rising working-capital needs put free cash flow conversion under scrutiny.
Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Plexus Corp. (NASDAQ: PLXS - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target
Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript
Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript
Plexus Q3 Earnings Call Highlights
Plexus NASDAQ: PLXS reported record fiscal third-quarter revenue of $1.305 billion, exceeding its guidance range and rising 12% sequentially and 28% from a year earlier, as demand strengthened across its aerospace and defense, healthcare life sciences, and industrial markets.
Plexus' Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
PLXS beats fiscal Q3 estimates as revenues jump 28%, fueled by Industrial strength, program ramps and broad demand, while its outlook signals more growth.
Here's What Key Metrics Tell Us About Plexus (PLXS) Q3 Earnings
Although the revenue and EPS for Plexus (PLXS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Plexus (PLXS) Surpasses Q3 Earnings and Revenue Estimates
Plexus (PLXS) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $1.9 per share a year ago.
Plexus Announces Fiscal Third Quarter Financial Results
NEENAH, WI, July 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026.
Castleark Management LLC Purchases New Position in Plexus Corp. $PLXS
Castleark Management LLC purchased a new position in Plexus Corp. (NASDAQ: PLXS) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,680 shares of the technology company's stock, valued at approximately $4,999,000. Castleark Management LLC owned 0.09% of Plexus
Plexus Sets Fiscal Third Quarter 2026 Earnings Release Date
NEENAH, WI, July 15, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal third quarter 2026 results after market close on Wednesday, July 29, 2026. Plexus' management will host a conference call to discuss its fiscal third quarter 2026 results on Thursday, July 30, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com.
Is Plexus Corp (PLXS) Overvalued After 3.6% Rally? GF Value Says Overvalued
On June 25, 2026, Plexus Corp (PLXS) shares rose 3.6% today, trading at $296.79. Over the past year, the stock has experienced significant volatility, with a 52
Price Targets
Plexus price target raised to $330 from $280 at Stifel
$330.00
(was $299.97)
Stifel Nicolaus
Plexus price target raised to $310 from $285 at Needham
$310.00
(was $268.36)
James Ricchiuti
·
Needham
Stifel Reiterates Buy Rating on Plexus (PLXS)
$280.00
(was $272.29)
Ruben Roy
·
Stifel Nicolaus
Plexus price target raised to $285 from $206 at Needham
$285.00
(was $250.58)
James Ricchiuti
·
Needham
Plexus price target raised to $275 from $205 at Raymond James
$275.00
(was $250.58)
Raymond James
Plexus upgraded to Buy from Hold at Stifel
$250.00
(was $228.64)
Stifel Nicolaus
Plexus price target raised to $200 from $150 at Stifel
$200.00
(was $197.60)
Ruben Roy
·
Stifel Nicolaus
Plexus price target raised to $195 from $165 at Benchmark
$195.00
(was $176.40)
David Williams
·
Williams Trading
Plexus price target raised to $150 from $140 at Stifel
$150.00
(was $149.00)
Stifel Nicolaus
Plexus price target raised to $165 from $160 at Benchmark
$165.00
(was $143.62)
David Williams
·
Williams Trading
Plexus price target lowered to $140 from $145 at Stifel
$140.00
(was $118.29)
Ruben Roy
·
Stifel Nicolaus
Plexus price target lowered to $145 from $152 at Stifel
$145.00
(was $125.35)
Ruben Roy
·
Stifel Nicolaus
Plexus price target raised to $150 from $145 at Benchmark
$150.00
(was $136.71)
David Williams
·
Williams Trading
Plexus (PLXS) PT Raised to $120 at Benchmark
$120.00
(was $102.86)
David Williams
·
Williams Trading
Plexus' Strength In Commercial Aerospace To Outweigh Demand Issues In Industrial And Healthcare Life Science Market: Analyst
$107.00
(was $96.72)
James Ricchiuti
·
Needham
Plexus price target raised to $105 from $101 at Benchmark
$105.00
(was $94.27)
David Williams
·
Williams Trading
Raymond James Upgrades Plexus (PLXS) to Outperform
$100.00
(was $86.54)
Adam Tindle
·
Raymond James
Needham Maintains Buy on Plexus, Raises Price Target to $93
$93.00
(was $82.60)
Needham